Nakatsuka, Yoshinari
Murase, Kimihiko
Sonomura, Kazuhiro
Tabara, Yasuharu
Nagasaki, Tadao
Hamada, Satoshi
Matsumoto, Takeshi
Minami, Takuma
Kanai, Osamu
Takeyama, Hirofumi
Sunadome, Hironobu
Takahashi, Naomi
Nakamoto, Isuzu
Tanizawa, Kiminobu
Handa, Tomohiro
Sato, Taka-Aki
Komenami, Naoko
Wakamura, Tomoko
Morita, Satoshi
Takeuchi, Osamu
Nakayama, Takeo
Hirai, Toyohiro
Kamatani, Yoichiro
Matsuda, Fumihiko
Chin, Kazuo
Funding for this research was provided by:
Mitsubishi Foundation
Daiwa Securities Health Foundation
Sumitomo Foundation
Takeda Medical Research Foundation
Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor and Welfare of Japan (H29-intractable diseases-general-027 and 20FC1027)
Research Foundation for Healthy Aging
Health, Labour and Welfare Sciences Research Grants, Research on Region Medical (H28-iryo-ippan-016, H30-iryo-ippan-009)
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (23K07638, 20H03690, 25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, 18K18450)
Japan Agency for Medical Research and Development (wm0425018, dk0207006, dk0207027, ek0210150, ek0109070, ek0109283, ek0109196, ek0109348, kk0205008, ek0210066, ek0210096, ek0210116, le0110005, ek0210150 and wm0425018)
Article History
Received: 6 July 2022
Accepted: 3 August 2023
First Online: 5 August 2023
Competing interests
: Yoshinari Nakatsuka reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, outside the submitted work; Kimihiko Murase reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, grants from Teijin Pharma, outside the submitted work; Kazuhiro Sonomura is an employee of Shimadzu during the conduct of the study; Yasuharu Tabara reports grants from Japan Agency for Medical Research and Development (AMED), grants from The Ministry of Education, Culture, Sports, Science & Technology in Japan, grants from Mitsubishi Foundation, grants from Daiwa Securities Health Foundation, grants from Sumitomo Foundation, during the conduct of the study; Tadao Nagasaki reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, outside the submitted work; Satoshi Hamada reports grants from Teijin Pharma, outside the submitted work; Hirofumi Takeyama reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, grants from Teijin Pharma, outside the submitted work; Hironobu Sunadome reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, outside the submitted work; Naomi Takahashi reports grants from Philips-Respironics, grants from ResMed, grants from Fukuda Denshi, grants from Fukuda Lifetec Keiji, outside the submitted work; Tomohiro Handa reports grants from Teijin Pharma, grants from Fujifilm corporation, outside the submitted work; Taka-Aki Sato is an employee of Shimadzu during the conduct of the study; Takeo Nakayama reports personal fees from Ohtsuka Pharamaceutical co., other from Japan Medical Data Center, personal fees from Dainippon Sumitomo Pharmaceutical co., personal fees from Ono Pharamaceutical co., personal fees from Chugai Pharamaceutical co., personal fees from Dentsu co., personal fees from Takeda Pharamaceutical co., personal fees from Novo Nordisk Pharma. co., personal fees from Janssen Pharmaceutical K.K. , personal fees from Boehringer Ingelheim International GmbH, other from HANSHIN Dispensing Holding Co.,Ltd., personal fees from Pfizer Japan Inc., personal fees from Nikkei Business Publications, Inc., personal fees from Eli Lilly Japan K.K., personal fees from Baxter, personal fees from Alexion, personal fees from Mitsubishi Tanabe Pharma Corporation, other from Nakagawa Pharmacy Co., Ltd., other from Toyota Tsusho All Life Co., personal fees from Mitsubishi Tanabe Pharma Corporation, outside the submitted work; Fumihiko Matsuda reports grants from Kyoto University, grants from Ministry of Education, Culture, Sports, Science & Technology in Japan, grants from Japan Agency for Medical Research and Development (AMED), grants from The Takeda Medical Research Foundation, during the conduct of the study; Kazuo Chin reports grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants from the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor and Welfare of Japan, grants from the Center of Innovation Program, and the Global University Project from Japan Science and Technology Agency, Japan Agency for Medical Research and Development, grants from the Research Foundation for Healthy Aging, grants from Health, Labour and Welfare Sciences Research Grants, Research on Region Medical, during the conduct of the study; grants and personal fees from Philips-Respironics, grants and personal fees from ResMed, grants and personal fees from Fukuda Denshi, grants and personal fees from Fukuda Lifetec Keiji and Tokyo, grants and personal fees from Teijin Pharma, grants from KYORIN Pharmaceutical Co., Ltd, grants from Nippon Boehringer Ingelheim Co., Ltd, grants and personal fees from GlaxoSmithKline, personal fees from MSD, personal fees from Astellas Pharma, personal fees from Eisai Co., Ltd., outside the submitted work. Takeshi Matsumoto, Takuma Minami, Osamu Kanai, Isuzu Nakamoto, Kiminobu Tanizawa, Tomoko Wakamura, Naoko Komenami, Satoshi Morita, Osamu Takeuchi, Toyohiro Hirai and Yoichiro Kamatani have nothing to disclose.